Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity

References

• Li C, Zhao T, Nie L et al. MicroRNA-223 decreases cell proliferation, migration, invasion, and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting Forkhead box O 1. Biosci Rep. 2020;40(10). doi: 10.1042/BSR20200485
   Google Scholar
• Yan W, Song L, Wang H, et al. Extracellular vesicles carrying miRNA-181b-5p affects the malignant progression of acute lymphoblastic leukemia. J Transl Med. 2021;19(1):511. doi: 10.1186/s12967-021-03174-w
   PubMed Web of Science ®Google Scholar
• Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2022;84:144–152. doi: 10.1016/j.semcancer.2020.10.013
   PubMed Web of Science ®Google Scholar
• Maugeri-Saccà M, de Maria R. The Hippo pathway in normal development and cancer. Pharmacol Ther. 2018;186:60–72. doi: 10.1016/j.pharmthera.2017.12.011
   PubMed Web of Science ®Google Scholar
• Nakajima M, Tanaka K, Yoneshima Y, et al. YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells. Biochem Biophys Res Commun. 2023;681:120–126. doi: 10.1016/j.bbrc.2023.09.067
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu X, Maglic D, et al. Comprehensive molecular characterization of the hippo signaling pathway in cancer. Cell Rep. 2018;25(5):1304–1317.e5. doi: 10.1016/j.celrep.2018.10.001
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang T, Zhang J, et al. Emerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity. Cancer Lett. Jul 10 2018;426:73–79. doi: 10.1016/j.canlet.2018.04.004. Epub 2018 Apr 11. PMID: 29654891.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Jia X, Zhang Y, et al. Tetrandrine induces apoptosis in human neuroblastoma through regulating the Hippo/YAP signaling pathway. Biochem Biophys Res Commun. 2019;513(4):846–851. doi: 10.1016/j.bbrc.2019.04.075
   PubMed Web of Science ®Google Scholar
• Wang T, Mao B, Cheng C, et al. YAP promotes breast cancer metastasis by repressing growth differentiation factor-15. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5):1744–1753. doi: 10.1016/j.bbadis.2018.02.020
   PubMed Web of Science ®Google Scholar
• Yin K, Dang S, Cui L, et al. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity. Biochem Biophys Res Commun. 2018;496(1):76–82. doi: 10.1016/j.bbrc.2017.12.170
   PubMed Web of Science ®Google Scholar
• Pauly M, Silverman LB. Diagnosis and treatment of childhood acute lymphoblastic leukemia. In: Wiernik PH, Dutcher JP Gertz MA, editors. Neoplastic diseases of the blood. Cham: Springer International Publishing; 2018. p. 307–335.
   Google Scholar
• Huang J, Wu S, Barrera J et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005;122(3):421–434. doi: 10.1016/j.cell.2005.06.007
   PubMed Web of Science ®Google Scholar
• Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol. 2008;20(6):638–646. doi: 10.1016/j.ceb.2008.10.001
   PubMed Web of Science ®Google Scholar
• Zaidi SK, Sullivan AJ, Medina R, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. Embo J. 2004;23(4):790–799. doi: 10.1038/sj.emboj.7600073
   PubMed Web of Science ®Google Scholar
• Cunningham R, Hansen CG. The hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond). 2022;136(3):197–222. doi: 10.1042/CS20201474
   PubMed Web of Science ®Google Scholar
• Cairns L, Tran T, Kavran JM. Structural insights into the regulation of hippo signaling. ACS Chem Biol. 2017;12(3):601–610. doi: 10.1021/acschembio.6b01058
   PubMed Web of Science ®Google Scholar
• Piccolo S, Panciera T, Contessotto P, et al. YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4(1):9–26. doi: 10.1038/s43018-022-00473-z
   PubMedGoogle Scholar
• Battilana G, Zanconato F, Piccolo S. Mechanisms of YAP/TAZ transcriptional control. Cell Stress. 2021;5(11):167–172. doi: 10.15698/cst2021.11.258
   PubMedGoogle Scholar
• Zhao X, Liu C, He X, et al. Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway. Front Oncol. 2022;12:1015709. doi: 10.3389/fonc.2022.1015709
   PubMed Web of Science ®Google Scholar
• Xu X, Li Y, Zhang R, et al. Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling. J Ethnopharmacol. 2023;311:116450. doi: 10.1016/j.jep.2023.116450
   PubMed Web of Science ®Google Scholar
• Gao R, Kalathur RKR, Coto‐Llerena M, et al. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med. 2021;13(12):e14351. doi: 10.15252/emmm.202114351
   PubMed Web of Science ®Google Scholar
• Zhang Y, An J, Shao Y, et al. CD38-directed vincristine nanotherapy for acute lymphoblastic leukemia. Biomacromolecules. 2022;23(1):377–387. doi: 10.1021/acs.biomac.1c01342
   PubMed Web of Science ®Google Scholar
• Uckun FM, Qazi S, Ozer Z, et al. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. Br J Haematol. 2011;153(6):741–752. doi: 10.1111/j.1365-2141.2011.08671.x
   PubMed Web of Science ®Google Scholar
• Teuffel O, Kuster SP, Hunger SP, et al. Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia. 2011;25(8):1232–1238. doi: 10.1038/leu.2011.84
   PubMed Web of Science ®Google Scholar